China kicks off emergency coronavirus vaccination for key groups in Wuhan

The Chinese city of Wuhan, where the coronavirus emerged a year ago, has started the emergency Covid-19 vaccination on some key groups, a senior health official said on Tuesday

Covid vaccine
Covid-19 vaccine
Press Trust of India Beijing
3 min read Last Updated : Dec 29 2020 | 12:30 PM IST

The Chinese city of Wuhan, where the novel coronavirus emerged a year ago before it became a pandemic and upended life across the globe, has started the emergency COVID-19 vaccination on some key groups, a senior health official said on Tuesday, even as China is yet to officially certify its multiple vaccines.

The vaccination, available at 48 designated clinics in 15 districts, began on December 24, targeting certain groups of people aged between 18 and 59 years, He Zhenyu, deputy director of the centre for disease control and prevention in Wuhan, told the media in Wuhan.

Those receiving the vaccine need to take two shots with an interval of four weeks, the state-run Xinhua news agency quoted He as saying.

As per the official Chinese time-line, the first cases of coronavirus emerged in Wuhan, the capital of Hubei province, on December 31 last year. The city of 11 million people went into lockdown from January 23, followed by the entire Hubei province.

The Hubei province and Wuhan lifted a prolonged lockdown on April 8 this year after the virus was brought under control. The death toll from the virus in Hubei province stood at 4,512, including 3,869 in Wuhan.

Hubei has so far reported 68,134 confirmed COVID-19 cases in total, including 50,339 in Wuhan.

In May this year, Wuhan conducted COVID-19 tests on almost all of its population following increasing concerns of a rebound of the pandemic, but the city reported fewer number of cases in the following months.

Chinese officials in some of the cities, including Beijing, have been conducting mass testing of people in the past few days in localities where cases have sprung up. China's National Health Commission announced on Tuesday that 27 new COVID-19 cases were reported in the Chinese mainland on Monday.

This included 15 locally transmitted cases and 12 arriving from outside the mainland. Seven new cases were reported in Beijing, the commission said in its daily report.

By the end of Monday, the total number of confirmed COVID-19 cases on the Chinese mainland reached 87,003, including 348 patients who are still receiving treatment.

A total of 82,021 patients have been discharged from the hospitals following their recovery and 4,634 have died as a result of the virus, according to the commission. China has been carrying out emergency use of its vaccines as the government evaluated data of clinical trials at home and abroad.

According to the officials, over a million people working in health and other critical sectors have been given vaccines under an emergency provision.

According to Yang Sheng, Deputy Director of China's National Medical Products Administration's drug registration bureau, a total of 11 Chinese vaccine candidates are in different stages of testing at home and abroad.

China has joined the COVAX, an international vaccine alliance.

The World Health Organisation (WHO) has said nine vaccine candidates, including two from China, are currently being evaluated for inclusion in the COVAX facility.

The COVAX is co-led by Gavi, an international vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO.

Globally, the number of coronavirus cases has topped 80.7 million, while the deaths have surged to more than 1.76 million, according to the Johns Hopkins University.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusChinaCoronavirus VaccineCoronavirus Tests

First Published: Dec 29 2020 | 12:04 PM IST

Next Story